BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with poor outcome. Resistance to treatment is associated with impaired vascularity, extensive hypoxia, and interstitial hypertension. In this study, the potential of dynamic contrast-enhanced (DCE)-MRI as a method for assessing the microvascular density (MVD), the fraction of hypoxic tissue, and the interstitial fluid pressure (IFP) of PDACs was investigated. MATERIAL AND METHODS: Intramuscular BxPC-3, Capan-2, MIAPaCa-2, and Panc-1 PDAC xenografts were used as preclinical models of human PDACs. DCE-MRI with Gd-DOTA as contrast agent was conducted with a 7.05-T scanner, and the DCE-MRI series were analyzed voxelwise by using the Tofts pharmacokinetic model. Tumor MVD and hypoxia were measured in histological preparations by using pimonidazole as a hypoxia marker and CD31 as a marker of endothelial cells. IFP was measured with a Millar catheter. RESULTS: Ktrans (the volume transfer constant of Gd-DOTA) increased with increasing MVD and decreased with increasing hypoxic fraction, but was not associated with IFP. Any association between ve (the fractional distribution volume of Gd-DOTA) and MVD, hypoxic fraction, or IFP could not be detected. CONCLUSIONS: This study shows that DCE-MRI is a useful modality for assessing important features of the microenvironment of PDAC xenografts and thus provides the basis for future preclinical and clinical DCE-MRI investigations of PDAC.
BACKGROUND:Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with poor outcome. Resistance to treatment is associated with impaired vascularity, extensive hypoxia, and interstitial hypertension. In this study, the potential of dynamic contrast-enhanced (DCE)-MRI as a method for assessing the microvascular density (MVD), the fraction of hypoxic tissue, and the interstitial fluid pressure (IFP) of PDACs was investigated. MATERIAL AND METHODS: Intramuscular BxPC-3, Capan-2, MIAPaCa-2, and Panc-1 PDAC xenografts were used as preclinical models of human PDACs. DCE-MRI with Gd-DOTA as contrast agent was conducted with a 7.05-T scanner, and the DCE-MRI series were analyzed voxelwise by using the Tofts pharmacokinetic model. Tumor MVD and hypoxia were measured in histological preparations by using pimonidazole as a hypoxia marker and CD31 as a marker of endothelial cells. IFP was measured with a Millar catheter. RESULTS: Ktrans (the volume transfer constant of Gd-DOTA) increased with increasing MVD and decreased with increasing hypoxic fraction, but was not associated with IFP. Any association between ve (the fractional distribution volume of Gd-DOTA) and MVD, hypoxic fraction, or IFP could not be detected. CONCLUSIONS: This study shows that DCE-MRI is a useful modality for assessing important features of the microenvironment of PDAC xenografts and thus provides the basis for future preclinical and clinical DCE-MRI investigations of PDAC.
Authors: Shun Kishimoto; Jeffrey R Brender; Gadisetti V R Chandramouli; Yu Saida; Kazutoshi Yamamoto; James B Mitchell; Murali C Krishna Journal: Antioxid Redox Signal Date: 2020-09-15 Impact factor: 7.468
Authors: Catherine S Wegner; Anette Hauge; Trude G Simonsen; Jon-Vidar Gaustad; Lise Mari K Andersen; Einar K Rofstad Journal: Neoplasia Date: 2018-06-19 Impact factor: 5.715
Authors: Edward Taylor; Jitao Zhou; Patricia Lindsay; Warren Foltz; May Cheung; Iram Siddiqui; Ali Hosni; Ahmed El Amir; John Kim; Richard P Hill; David A Jaffray; David W Hedley Journal: Sci Rep Date: 2020-01-31 Impact factor: 4.379
Authors: W Jeffrey Zabel; Nader Allam; Warren D Foltz; Costel Flueraru; Edward Taylor; I Alex Vitkin Journal: Sci Rep Date: 2022-02-24 Impact factor: 4.996
Authors: Nan Wang; Srinivas Gaddam; Lixia Wang; Yibin Xie; Zhaoyang Fan; Wensha Yang; Richard Tuli; Simon Lo; Andrew Hendifar; Stephen Pandol; Anthony G Christodoulou; Debiao Li Journal: Magn Reson Med Date: 2020-01-21 Impact factor: 4.668
Authors: Remy Klaassen; Anne Steins; Oliver J Gurney-Champion; Maarten F Bijlsma; Geertjan van Tienhoven; Marc R W Engelbrecht; Casper H J van Eijck; Mustafa Suker; Johanna W Wilmink; Marc G Besselink; Olivier R Busch; Onno J de Boer; Marc J van de Vijver; Gerrit K J Hooijer; Joanne Verheij; Jaap Stoker; Aart J Nederveen; Hanneke W M van Laarhoven Journal: Mol Oncol Date: 2020-06-23 Impact factor: 6.603